Abstract:Background: The AT-rich interaction domain 1A (ARID1A) is thought to be a tumor suppressive gene, and most of its mutations result in loss of expression of ARID1A protein. Combined with SIRPα on the surface of macrophages, CD47 on the surface of cancer cells can send an antiphagocytic "Don't eat me" signal to the immune system that helps to avoid immune surveillance. However, the relationship between ARID1A and CD47 expression and their prognostic value in gastric cancer (GC) are still unknown. Methods: In this study, we evaluated ARID1A and CD47 expression in 154 GC patients' tissues using tissue microarray. Expressions of ARID1A and CD47 in GC cell lines were determined by western blot and quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) techniques, and cell membranous CD47 expression was quantified by flow cytometry. In addition, chromatin immunoprecipitation (ChIP)-qPCR was used to determine the aspects of regulation of CD47 by ARID1A. The proportions of tumor-infiltrating immune cells were estimated on The Cancer Genome Atlas (TCGA) data set by using quanTIseq and EPIC algorithms. The infiltration of M1-polarized macrophages, M2-polarized macrophages, and regulatory T cells (Tregs) in GC tissues was determined by multispectral immunofluorescence. Results: A significant correlation was found between loss of ARID1A and high expression of CD47 at protein level in GC. By integrating 375 bulk RNA sequencing samples from TCGA data set, we found that mutated ARID1A correlated with high CD47 expression. In GC cell lines, knockdown of ARID1A significantly increased CD47 expression both at protein and mRNA levels as measured by western blot, qRT-PCR, and flow cytometry. Moreover, ChIP-qPCR revealed that CD47 was a direct downstream target gene of ARID1A in GC. Utilizing univariate and multivariate survival analyses, we found that patients with ARID1AlossCD47high expression had a worse prognosis. Estimation of infiltrating immune cells on TCGA data set showed that a higher infiltration proportion of M2 macrophages and Tregs was found in ARID1A mutated CD47 high expression subgroup. Furthermore, application of multispectral immunofluorescence revealed a higher infiltration proportion of M2 macrophages and Tregs in ARID1AlossCD47high GC tissues. Conclusion: Loss of ARID1A is strongly correlated with high CD47 expression in GC, and combination of ARID1A and CD47 is a promising prognosis factor in GC.

Significant association of DIRC1 overexpression with tumor progression and poor prognosis in gastric cancer.

LINC01857 promotes the development of gastric cancer by regulating microRNA-200b.

ASF1b is a Novel Prognostic Predictor Associated with Cell Cycle Signaling Pathway in Gastric Cancer

MiR-301a-5p/SCIN promotes gastric cancer progression via regulating STAT3 and NF-κB signaling

DZIP1 Expression As a Prognostic Marker in Gastric Cancer: A Bioinformatics-Based Analysis

The role of DOT1L in the proliferation and prognosis of gastric cancer

CRISPLD1 Promotes Gastric Cancer Progression by Regulating the Ca2+/PI3K-AKT Signaling Pathway

Circ_0009910 Regulates Growth and Metastasis and is Associated with Poor Prognosis in Gastric Cancer.

Comprehensive Analysis Reveals CTHRC1, SERPINE1, VCAN and UPK1B As the Novel Prognostic Markers in Gastric Cancer.

Combinatorial Analysis of AT-Rich Interaction Domain 1A and CD47 in Gastric Cancer Patients Reveals Markers of Prognosis.

Over-Expression of ARID3B Suppresses Tumor Progression and Predicts Better Prognosis in Patients with Gastric Cancer.

Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment

Long non-coding RNA AC010457.1 promotes the growth and EMT of gastric cancer via the PI3K/AKT axis

IDDF2019-ABS-0263 Androgen Receptor Promotes Gastric Carcinogenesis Via Upregulating the Expression of Cell Cycle-Related Kinase

Expression of DCP1a in gastric cancer and its biological function and mechanism in chemotherapy resistance in gastric cancer cells

Overexpression of CrkL as a novel biomarker for poor prognosis in gastric cancer

The serine protease CORIN promotes progression of gastric cancer by mediating the ERK1/2 MAPK pathway

AKR1C3 mediates gastric cancer cell invasion and metastasis via the AKT and JNK/p-NF-κB signaling pathways

Expression Characteristics of Cdc20 in Gastric Cancer and Its Correlation with Poor Prognosis

Circ1811 suppresses gastric cancer progression by regulating the miR-632/DAPK1 axis

Comprehensive Analysis of Cell-Extracellular Matrix Protein Ras Suppressor-1 in Function and Prognosis of Gastrointestinal Cancers.